CSc1nc(NCc2ccco2)c2sc3nc(C(C)C)c4c(c3c2n1)CC(C)(C)OC4
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?